Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2000; 36:2036-2043
© 2000 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Figueras, J.
Right arrow Articles by Soler-Soler, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Figueras, J.
Right arrow Articles by Soler-Soler, J.

Thrombin formation and fibrinolytic activity in patients with acute myocardial infarction or unstable angina: in-hospital course and relationship with recurrent angina at rest

Jaume Figueras, MDa,b, Yasone Monasterio, MDa,b, Rosa Maria Lidón, MDa,b, Elsa Nieto, RNa,b and Jordi Soler-Soler, MDa,b

a Unitat Coronària, Servei de Cardiologia, Hospital General Vall d’Hebron, Barcelona, Spain
b Unitat de Recerca d’Hemostàsia, Hospital General Vall d’Hebron, Barcelona, Spain



View larger version (33K):

[in a new window]
 
Figure 1 Thrombin-antithrombin complex (upper panel) and fibrinogen plasma levels (lower panel) (mean ± SEM) on days 1 and 10 and at 3 months in patients with unstable angina or acute myocardial infarction with (dashed bars) or without in-hospital angina (open bars). Also shown are values from a control group. Thrombin-antithrombin complex values at the three stages were higher in patients than they were in the control group (see text). There were significant (*) intragroup differences (ANOVA) in the two subsets as well as a trend towards intergroup differences (ANOVA, p < 0.077), mainly because of the higher values at 10 days in patients with in-hospital angina than in those without (p < 0.013). Fibrinogen levels were also higher in patients than they were in the control group and increased significantly at 10 days to a comparable extent in patients with or without in-hospital angina. Intragroup differences (ANOVA) were significant (*). ANOVA = analysis of variance.

 


View larger version (31K):

[in a new window]
 
Figure 2 D-dimer (upper panel) and PAI-1 plasma levels (lower panel) (mean ± SEM) on days 1 and 10 and at 3 months in patients with unstable angina or acute myocardial infarction with (dashed bars) or without in-hospital angina (open bars) and in those from a control group. D-dimer values at the three stages were higher in patients than they were in the control group (see text). There were significant intragroup differences (*) (ANOVA) in the two subsets as well as intergroup differences (ANOVA, p < 0.029). At 10 days values were significantly higher in patients with in-hospital angina than they were in those without (p < 0.004). Plasminogen activator inhibitor, type 1 levels were also higher in patients than they were in the control group, and there were significant (*) intragroup (ANOVA) as well as intergroup differences (ANOVA, p < 0.029). The latter were mainly related to the particularly higher PAI-1 levels on day one in patients who developed in-hospital angina than in those who did not (p < 0.008). ANOVA = analysis of variance; PAI-1 = plasminogen activator inhibitor, type 1.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement